Effect of combined spinal-epidural analgesia versus epidural analgesia on labor and delivery duration

Francisco Pascual-Ramirez, Javier Haya, Faustino R. Pérez-López, Silvia Gil-Trujillo, Rosa A. Garrido-Esteban, Ginés Bernal

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: To determine whether combined spinal-epidural analgesia (CSEA) can decrease the known epidural effect of lengthening delivery. Methods: Between April and May 2010, 144 women undergoing childbirth in hospital with epidural pain relief were randomized to receive either low-dose epidural analgesia (LEA) or CSEA. The spinal component included 2.5 mg of bupivacaine, 25 μg of fentanyl, and 200 μg of morphine. The epidural component of the CSEA procedure was started once pain returned. The primary outcome was total labor duration measured from the time of initiation of labor analgesia to delivery. Results: The difference in duration between LEA (n = 72) and CSEA (n = 72) was 5 minutes for labor (P = 0.82), 2 minutes for delivery (P = 0.60), and 7 minutes for total labor duration (P = 0.75). The combined group used less levobupivacaine (P < 0.001) and had lower sensory blockade at the dermatomal level (P = 0.037). Women in the CSEA group had a higher incidence of pruritus (P = 0.002) and lightheadedness (P = 0.02) during labor; and a higher incidence of pruritus (P = 0.002), nausea-vomiting (P = 0.026), and drowsiness (P = 0.003) in the postpartum period. Conclusion: As compared with LEA, CSEA did not shorten the duration of labor length; however, it did reduce levobupivacaine consumption and motor weakness.

Original languageEnglish (US)
Pages (from-to)246-250
Number of pages5
JournalInternational Journal of Gynecology and Obstetrics
Volume114
Issue number3
DOIs
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Epidural Analgesia
Pruritus
Pain
Sleep Stages
Bupivacaine
Incidence
Dizziness
Fentanyl
Analgesia
Postpartum Period
Morphine
Nausea
Vomiting
Parturition

Keywords

  • Combined spinal-epidural analgesia
  • Labor and delivery duration
  • Labor epidural analgesia
  • Morphine spinal analgesia
  • Randomized trial

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Effect of combined spinal-epidural analgesia versus epidural analgesia on labor and delivery duration. / Pascual-Ramirez, Francisco; Haya, Javier; Pérez-López, Faustino R.; Gil-Trujillo, Silvia; Garrido-Esteban, Rosa A.; Bernal, Ginés.

In: International Journal of Gynecology and Obstetrics, Vol. 114, No. 3, 01.01.2011, p. 246-250.

Research output: Contribution to journalArticle

Pascual-Ramirez, Francisco ; Haya, Javier ; Pérez-López, Faustino R. ; Gil-Trujillo, Silvia ; Garrido-Esteban, Rosa A. ; Bernal, Ginés. / Effect of combined spinal-epidural analgesia versus epidural analgesia on labor and delivery duration. In: International Journal of Gynecology and Obstetrics. 2011 ; Vol. 114, No. 3. pp. 246-250.
@article{e6ca0b6f3d9f424abb2bd93f06d74418,
title = "Effect of combined spinal-epidural analgesia versus epidural analgesia on labor and delivery duration",
abstract = "Objective: To determine whether combined spinal-epidural analgesia (CSEA) can decrease the known epidural effect of lengthening delivery. Methods: Between April and May 2010, 144 women undergoing childbirth in hospital with epidural pain relief were randomized to receive either low-dose epidural analgesia (LEA) or CSEA. The spinal component included 2.5 mg of bupivacaine, 25 μg of fentanyl, and 200 μg of morphine. The epidural component of the CSEA procedure was started once pain returned. The primary outcome was total labor duration measured from the time of initiation of labor analgesia to delivery. Results: The difference in duration between LEA (n = 72) and CSEA (n = 72) was 5 minutes for labor (P = 0.82), 2 minutes for delivery (P = 0.60), and 7 minutes for total labor duration (P = 0.75). The combined group used less levobupivacaine (P < 0.001) and had lower sensory blockade at the dermatomal level (P = 0.037). Women in the CSEA group had a higher incidence of pruritus (P = 0.002) and lightheadedness (P = 0.02) during labor; and a higher incidence of pruritus (P = 0.002), nausea-vomiting (P = 0.026), and drowsiness (P = 0.003) in the postpartum period. Conclusion: As compared with LEA, CSEA did not shorten the duration of labor length; however, it did reduce levobupivacaine consumption and motor weakness.",
keywords = "Combined spinal-epidural analgesia, Labor and delivery duration, Labor epidural analgesia, Morphine spinal analgesia, Randomized trial",
author = "Francisco Pascual-Ramirez and Javier Haya and P{\'e}rez-L{\'o}pez, {Faustino R.} and Silvia Gil-Trujillo and Garrido-Esteban, {Rosa A.} and Gin{\'e}s Bernal",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.ijgo.2011.04.004",
language = "English (US)",
volume = "114",
pages = "246--250",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Effect of combined spinal-epidural analgesia versus epidural analgesia on labor and delivery duration

AU - Pascual-Ramirez, Francisco

AU - Haya, Javier

AU - Pérez-López, Faustino R.

AU - Gil-Trujillo, Silvia

AU - Garrido-Esteban, Rosa A.

AU - Bernal, Ginés

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Objective: To determine whether combined spinal-epidural analgesia (CSEA) can decrease the known epidural effect of lengthening delivery. Methods: Between April and May 2010, 144 women undergoing childbirth in hospital with epidural pain relief were randomized to receive either low-dose epidural analgesia (LEA) or CSEA. The spinal component included 2.5 mg of bupivacaine, 25 μg of fentanyl, and 200 μg of morphine. The epidural component of the CSEA procedure was started once pain returned. The primary outcome was total labor duration measured from the time of initiation of labor analgesia to delivery. Results: The difference in duration between LEA (n = 72) and CSEA (n = 72) was 5 minutes for labor (P = 0.82), 2 minutes for delivery (P = 0.60), and 7 minutes for total labor duration (P = 0.75). The combined group used less levobupivacaine (P < 0.001) and had lower sensory blockade at the dermatomal level (P = 0.037). Women in the CSEA group had a higher incidence of pruritus (P = 0.002) and lightheadedness (P = 0.02) during labor; and a higher incidence of pruritus (P = 0.002), nausea-vomiting (P = 0.026), and drowsiness (P = 0.003) in the postpartum period. Conclusion: As compared with LEA, CSEA did not shorten the duration of labor length; however, it did reduce levobupivacaine consumption and motor weakness.

AB - Objective: To determine whether combined spinal-epidural analgesia (CSEA) can decrease the known epidural effect of lengthening delivery. Methods: Between April and May 2010, 144 women undergoing childbirth in hospital with epidural pain relief were randomized to receive either low-dose epidural analgesia (LEA) or CSEA. The spinal component included 2.5 mg of bupivacaine, 25 μg of fentanyl, and 200 μg of morphine. The epidural component of the CSEA procedure was started once pain returned. The primary outcome was total labor duration measured from the time of initiation of labor analgesia to delivery. Results: The difference in duration between LEA (n = 72) and CSEA (n = 72) was 5 minutes for labor (P = 0.82), 2 minutes for delivery (P = 0.60), and 7 minutes for total labor duration (P = 0.75). The combined group used less levobupivacaine (P < 0.001) and had lower sensory blockade at the dermatomal level (P = 0.037). Women in the CSEA group had a higher incidence of pruritus (P = 0.002) and lightheadedness (P = 0.02) during labor; and a higher incidence of pruritus (P = 0.002), nausea-vomiting (P = 0.026), and drowsiness (P = 0.003) in the postpartum period. Conclusion: As compared with LEA, CSEA did not shorten the duration of labor length; however, it did reduce levobupivacaine consumption and motor weakness.

KW - Combined spinal-epidural analgesia

KW - Labor and delivery duration

KW - Labor epidural analgesia

KW - Morphine spinal analgesia

KW - Randomized trial

UR - http://www.scopus.com/inward/record.url?scp=79961169257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961169257&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2011.04.004

DO - 10.1016/j.ijgo.2011.04.004

M3 - Article

VL - 114

SP - 246

EP - 250

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 3

ER -